ArticlebioRxiv : the preprint server for biology2026
Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.
Breanna Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.